This bill directs the Food and Drug Administration to conduct a comprehensive study on reprocessing single-use medical devices, which are medical instruments typically designed for one-time use but that could potentially be safely reused after being cleaned and sterilized. The study must prioritize patient safety and infection prevention while examining FDA approval pathways, the role of third-party reprocessing companies versus hospital in-house reprocessing, operational feasibility, and financial and environmental benefits and costs. The FDA must also consult with hospitals, clinicians, infection prevention organizations, and other relevant federal agencies like the CDC and CMS to gather input for the study. Within one year of the bill's enactment, the Secretary of Health and Human Services must report findings to Congress, including which devices could potentially be reprocessed and recommendations for establishing reprocessing programs. The bill does not specify dedicated funding amounts but requires the FDA to complete and report its findings within a one-year timeline.